Ethnic Differences in Antihypertensive Medication Use in the Elderly

Annals of Pharmacotherapy

Volumn 38, Issue 2, 2004, Pages 209-214

  Raji, Mukaila A ^a   Kuo, Yong Fang ^b   Salazar, Joel A ^b   Satish, Shiva ^b   Goodwin, James S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Elderly; Ethnicity; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CAUCASIAN; COGNITION; CONSULTATION; DAILY LIFE ACTIVITY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; HYPERTENSION; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEGRO; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; HYPERTENSION; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; NUTRITION SURVEYS; PATIENT COMPLIANCE; SOCIAL CLASS; TEXAS;

EID: 1642580705     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D224     Document Type: Article

References (25)

1. Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults. The Cardiovascular Health Study. Arch Intern Med 2002;162:2325-32.
2. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-86.
3. Sudano JJ Jr, Baker DW. Antihypertensive medication use in Hispanic adults: a comparison with black and white adults. Med Care 2001;39:575-87.
4. Espino DV, Lichtenstein MJ, Hazuda HP, Fabrizio D, Wood RC, Goodwin J, et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: the Hispanic EPESES study. Established Population for the Epidemiologic Study of the Elderly. J Am Geriatr Soc 1998;46:1228-34.
5. Satish S, Stroup-Benham CA, Espino DV, Markides KS, Goodwin JS. Under treatment of hypertension in older Mexican Americans. J Am Geriatr Soc 1998;46:405-10.
6. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
7. Amery A, Birkenhager W, Brixko R, Bulpitt C, Clement D, Deruyttere M, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986;2:589-92.
8. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
10. US Bureau of the Census. 65+ in the United States (current population reports, special studies P23-190). Washington, DC: US Government Printing Office, 1996.
11. Gueyffier F, Bulpitt C, Boissel J-P, Ekbom T, Fagard R, Casiglia E, et al., for the INDANA group. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 1999;353:793-6.
12. Goodwin JS, Black SA, Satish S. Aging versus disease: the opinions of older black, Hispanic, and non-Hispanic white Americans about the causes and treatment of common medical conditions. J Am Geriatr Soc 1999;47:973-9.
13. Black SA, Rush RD. Cognitive and functional decline in adults aged 75 and older. J Am Geriatr Soc 2002;50:1978-86.
14. Cornoni-Huntley J, Brock DB, Ostfeld AM, Taylor JO, Wallace RB, eds. Established populations for epidemiological studies of the elderly, resource data book. NIH Publication No. 86-2443. Bethesda, MD: National Institutes of Health, 1986.
15. Anatomical Therapeutic Chemical (ATC) classification system. Oslo, Norway, March 14th, 2002. www.who.int/medicines/organization/par/edl/example3.doc (accessed 2003 May 9).
16. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-9.
17. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
18. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficits in elderly patients. J Am Geriatr Soc 1975;13:433-9.
19. Martinez de la Iglesia J, Duenas Herrero R, Onis Vilches MC, Aguado Taberne C, Albert Colomer C, Luque Luque R. Spanish language adaptation and validation of the Pfeiffer's questionnaires (SPMSQ) to detect cognitive deterioration in people over 65 years of age. Med Clin (Barc) 2001;117:129-34.
20. Pappas G, Gergen PJ, Carroll M. Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic Health and Nutrifion Examination Survey (HHANES), 1982-84. Am J Public Health 1990;80:1431-6.
21. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for community dwelling elderly. JAMA 1994;272:292-6.
22. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002;287:337-44.
23. Satish S, Markides KS, Zhang D, Goodwin JS. Factors influencing unawareness of hypertension among older Mexican Americans. Prev Med 1997;26:645-50.
24. Okuno J, Yanagi H, Tomura S. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol 2001;57:589-94.
25. Saha S, Komaromy M, Koepsell TD, Bindman AB. Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med 1999;159:997-1004.